Olesya Solheim

418 total citations
14 papers, 204 citations indexed

About

Olesya Solheim is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, Olesya Solheim has authored 14 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Olesya Solheim's work include Ovarian cancer diagnosis and treatment (8 papers), Testicular diseases and treatments (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Olesya Solheim is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Testicular diseases and treatments (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Olesya Solheim collaborates with scholars based in Norway, Italy and France. Olesya Solheim's co-authors include Claes G. Tropé, Sophie D. Fosså, J. Kærn, Jahn M. Nesland, Alv A. Dahl, Helga B. Salvesen, Sophie D. Fosså, Johan Haux, Terje Osnes and Bjørn Hagen and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Modern Pathology.

In The Last Decade

Olesya Solheim

13 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olesya Solheim Norway 8 102 78 57 35 34 14 204
Dagmara Klasa-Mazurkiewicz Poland 8 62 0.6× 36 0.5× 65 1.1× 88 2.5× 34 1.0× 34 250
Liz-Anne Lewsley United Kingdom 9 87 0.9× 40 0.5× 141 2.5× 77 2.2× 9 0.3× 18 254
Jacob Tangir United States 9 327 3.2× 114 1.5× 85 1.5× 160 4.6× 159 4.7× 12 495
Brenda Hermsen Netherlands 7 157 1.5× 22 0.3× 56 1.0× 41 1.2× 28 0.8× 16 286
Helena Mörse Sweden 10 65 0.6× 23 0.3× 24 0.4× 83 2.4× 169 5.0× 19 312
J. Gillen United States 6 25 0.2× 18 0.2× 31 0.5× 43 1.2× 14 0.4× 17 158
Ginés Hernández-Cortes Spain 5 93 0.9× 61 0.8× 30 0.5× 56 1.6× 3 0.1× 8 179
Heather Miller United States 8 43 0.4× 16 0.2× 27 0.5× 56 1.6× 8 0.2× 20 154
Pradeep Panuganti United States 5 130 1.3× 17 0.2× 46 0.8× 202 5.8× 9 0.3× 6 323
Virginie Kinet Belgium 7 33 0.3× 13 0.2× 18 0.3× 62 1.8× 57 1.7× 12 190

Countries citing papers authored by Olesya Solheim

Since Specialization
Citations

This map shows the geographic impact of Olesya Solheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olesya Solheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olesya Solheim more than expected).

Fields of papers citing papers by Olesya Solheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olesya Solheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olesya Solheim. The network helps show where Olesya Solheim may publish in the future.

Co-authorship network of co-authors of Olesya Solheim

This figure shows the co-authorship network connecting the top 25 collaborators of Olesya Solheim. A scholar is included among the top collaborators of Olesya Solheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olesya Solheim. Olesya Solheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Turashvili, Gulisa, Sabrina Croce, Olesya Solheim, et al.. (2025). A Distinctive DICER1-Related Wilms-Like Uterine Tumor: A Report of Eight Cases. Modern Pathology. 38(12). 100895–100895.
2.
Bentzen, Anne Gry, Elisabeth Berge Nilsen, Ingvild Vistad, et al.. (2023). Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer. International Journal of Gynecological Cancer. 33(12). 1898–1905. 4 indexed citations
3.
Joneborg, Ulrika, Alice Bergamini, Emelie Wallin, et al.. (2023). European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors. International Journal of Gynecological Cancer. 33(10). 1621–1626. 4 indexed citations
4.
Nilsen, Elisabeth Berge, Ingvild Vistad, Anne Dørum, et al.. (2021). Real-life data of niraparib maintenance treatment in patients with recurrent platinum-sensitive ovarian cancer.. Journal of Clinical Oncology. 39(15_suppl). 5560–5560. 2 indexed citations
5.
Türzer, Martin, et al.. (2019). Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer. Journal of Gynecologic Oncology. 30(4). e56–e56. 17 indexed citations
6.
Solheim, Olesya, et al.. (2018). Long‐term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin‐based chemotherapy for malignant ovarian germ cell tumor. Acta Obstetricia Et Gynecologica Scandinavica. 98(2). 240–249. 9 indexed citations
7.
Oldenburg, Jan, et al.. (2018). PD-1 inhibitor treatment of platinum-resistant epithelial ovarian cancer.. Journal of Clinical Oncology. 36(15_suppl). e17555–e17555. 2 indexed citations
8.
Solheim, Olesya, Sophie D. Fosså, Milada Cvancarova Småstuen, et al.. (2017). Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer. Gynecologic Oncology. 145(1). 148–153. 28 indexed citations
9.
Solheim, Olesya, et al.. (2017). Epithelial–mesenchymal transition markers in malignant ovarian germ cell tumors. Apmis. 125(9). 781–786. 10 indexed citations
10.
Vistad, Ingvild, Line Bjørge, Olesya Solheim, et al.. (2017). A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. Acta Obstetricia Et Gynecologica Scandinavica. 96(10). 1162–1169. 25 indexed citations
11.
12.
Solheim, Olesya, Claes G. Tropé, J. Kærn, et al.. (2014). Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the “cisplatin era”. Gynecologic Oncology. 136(2). 224–229. 35 indexed citations
13.
Solheim, Olesya, J. Kærn, Claes G. Tropé, et al.. (2013). Malignant ovarian germ cell tumors: Presentation, survival and second cancer in a population based Norwegian cohort (1953–2009). Gynecologic Oncology. 131(2). 330–335. 44 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dagmara Klasa-Mazurkiewicz Breakdown of academic impact, for papers by Liz-Anne Lewsley Breakdown of academic impact, for papers by Jacob Tangir Breakdown of academic impact, for papers by Brenda Hermsen Breakdown of academic impact, for papers by Helena Mörse Breakdown of academic impact, for papers by J. Gillen Breakdown of academic impact, for papers by Ginés Hernández-Cortes Breakdown of academic impact, for papers by Heather Miller Breakdown of academic impact, for papers by Pradeep Panuganti Breakdown of academic impact, for papers by Virginie Kinet
Rankless by CCL
2026